אולנזאפין דקסל 5 מ"ג

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

OLANZAPINE 5 MG

Tilgjengelig fra:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-kode:

N05AH03

Legemiddelform:

TABLETS

Administreringsrute:

PER OS

Produsert av:

DEXCEL LTD

Terapeutisk gruppe:

OLANZAPINE

Indikasjoner:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Autorisasjon dato:

2012-05-01